Eversept Partners
$1.5B 13F equity value
135 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP DEL | 264,271 | $157M | 10.3% |
| ABVX | ABIVAX SA | 934,423 | $104M | 6.9% |
| GSK | GSK PLC | 1,785,175 | $99M | 6.5% |
| VERA | VERA THERAPEUTICS INC | 2,173,286 | $87M | 5.8% |
| NTRA | NATERA INC | 384,713 | $77M | 5.1% |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,885,622 | $67M | 4.4% |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,788,016 | $57M | 3.7% |
| PCVX | VAXCYTE INC | 924,193 | $54M | 3.5% |
| BKD | BROOKDALE SR LIVING INC | 3,568,555 | $49M | 3.2% |
| IONS | IONIS PHARMACEUTICALS INC | 632,100 | $47M | 3.1% |
Track Eversept Partners's 13F portfolio: $1.5B in reported holdings, 135 positions. Top holdings and quarterly changes on SentiSense.